Experiment summary for ENCSR000EIT
doi:10.17989/ENCSR000EIT
Summary
- Status
- released
- Assay
- DNase-seq
- Biosample summary
- Homo sapiens GM03348 genetically modified (insertion) using transduction targeting H. sapiens MYOD1 treated with 3 μg/mL doxycycline for 10 days
- Biosample Type
- cell line
- Replication type
- unreplicated
- Description
- DNase-seq on human fibroblast (GM03348) treated with lentiviral MyoD
- Treatments
- 3 μg/mL doxycycline (CHEBI:50845) for 10 days
- Nucleic acid type
- DNA
- Fragmentation methods
- see document
- Platform
- Illumina Genome Analyzer
Attribution
ENCODE2 project
- Lab
- Gregory Crawford, Duke
- Award
- U54HG004563 (Gregory Crawford, Duke)
- Project
- ENCODE
- External resources
- Date submitted
- January 11, 2011
- Date released
- August 28, 2012
- Annotation (gkmsvm-model)
Isogenic replicates
Isogenic replicate | Technical replicate | Summary | Biosample | Modifications | Library |
---|---|---|---|---|---|
1 | 1 | Homo sapiens GM03348 cell line genetically modified (insertion) using transduction targeting H. sapiens MYOD1 treated with 3 μg/mL doxycycline for 10 days | ENCBS558ENC | ENCGM883SVN | ENCLB443LVF |
1 | 2 | Homo sapiens GM03348 cell line genetically modified (insertion) using transduction targeting H. sapiens MYOD1 treated with 3 μg/mL doxycycline for 10 days | ENCBS558ENC | ENCGM883SVN | ENCLB067NZK |